The Scottish Medicines Consortium has issued its monthly advice on new medicines.
Glyceryl trinitrate 0.4% ointment (Rectogesic®) was rejected because the economic case was insufficiently robust to gain acceptance. This was the fourth submission to be rejected.
Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.